about
Brain injury in the international multicenter randomized SafeBoosC phase II feasibility trial: cranial ultrasound and magnetic resonance imaging assessments.The SafeBoosC II randomized trial: treatment guided by near-infrared spectroscopy reduces cerebral hypoxia without changing early biomarkers of brain injury.Predictive Role of F2-Isoprostanes as Biomarkers for Brain Damage after Neonatal Surgery.Neonatal DTI early after birth predicts motor outcome in preterm infants with periventricular hemorrhagic infarction.Early Prediction of Hypoxic-Ischemic Brain Injury by a New Panel of Biomarkers in a Population of Term NewbornsPredictive Role of Urinary Metabolic Profile for Abnormal MRI Score in Preterm NeonatesPerioperative neonatal brain injury is associated with worse school-age neurodevelopment in children with critical congenital heart diseaseBrain and CSF Volumes in Fetuses and Neonates with Antenatal Diagnosis of Critical Congenital Heart Disease: A Longitudinal MRI Study
P50
Q38942492-0FB24194-2E67-41AE-81F7-3B18B422DA60Q40200067-FF14E115-AFE9-475B-9115-D03B2C7C9AD3Q47156357-A2F515FE-E790-4A1E-A723-59CDA43D46DFQ48175187-CF8AA668-04C8-43A2-88E5-CA2288B355BBQ58188917-507EEF68-C03A-4B3C-87E7-F6A87EF0B208Q58591209-46F7CBF9-99F0-4A9F-80FF-080CBA79224AQ88154511-9910F65A-F463-4FE9-9399-1B253C31F4F0Q92686537-CECE5796-F5D3-4CC6-9037-922C1D02576B
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Manon Benders
@en
Manon Benders
@nl
type
label
Manon Benders
@en
Manon Benders
@nl
prefLabel
Manon Benders
@en
Manon Benders
@nl
P31
P496
0000-0001-5491-9168